Related references
Note: Only part of the references are listed.Physicochemical and biological characterization of SB2, a biosimilar of Remicade® (infliximab)
Juyong Hong et al.
MABS (2017)
Fc glycans of therapeutic antibodies as critical quality attributes
Dietmar Reusch et al.
GLYCOBIOLOGY (2015)
The choice of mammalian cell host and possibilities for glycosylation engineering
Michael Butler et al.
CURRENT OPINION IN BIOTECHNOLOGY (2014)
Physicochemical characterization of Remsima®
Soon Kwan Jung et al.
MABS (2014)
Quantitative evaluation of fucose reducing effects in a humanized antibody on Fcy receptor binding and antibody-dependent cell-mediated cytotoxicity activities
Shan Chung et al.
MABS (2012)
Galactosylation variations in marketed therapeutic antibodies
T. Shantha Raju et al.
MABS (2012)
Development of a quantitative, cell-line based assay to measure ADCC activity mediated by therapeutic antibodies
Alfred Schnueriger et al.
MOLECULAR IMMUNOLOGY (2011)
Two mechanisms of the enhanced antibody-dependent cellular cytotoxicity (ADCC) efficacy of non-fucosylated therapeutic antibodies in human blood
Shigeru Iida et al.
BMC CANCER (2009)
Terminal sugars of Fc glycans influence antibody effector functions of IgGs
T. Shantha Raju
CURRENT OPINION IN IMMUNOLOGY (2008)
Development of a simple and rapid method for producing non-fucosylated oligomannose containing antibodies with increased effector function
Quin Zhou et al.
BIOTECHNOLOGY AND BIOENGINEERING (2008)
Increased natural killer cell expression of CD16, augmented binding and ADCC activity to rituximab among individuals expressing the FcγRIIIa-158 V/V and V/F polymorphism
Evdoxia Hatjiharissi et al.
BLOOD (2007)
Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality
Bernard J. Scallon et al.
MOLECULAR IMMUNOLOGY (2007)
IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides
R Niwa et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2005)
Enhanced natural killer cell binding and activation by low-fucose IgG1 antibody results in potent antibody-dependent cellular cytotoxicity induction at lower antigen density
R Niwa et al.
CLINICAL CANCER RESEARCH (2005)
Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity
RL Shields et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
